Class information for:
Level 1: IAVI NEUTRALIZING ANTIBODY//DUKE HUMAN VACCINE//HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
768 3003 54.8 92%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
40 31853 AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//AIDS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 IAVI NEUTRALIZING ANTIBODY Address 154 87% 2% 75
2 DUKE HUMAN VACCINE Address 77 46% 4% 125
3 HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER Address 70 78% 2% 46
4 INT AIDS VACCINE INITIAT NEUTRALIZING ANTIBODY CT Address 69 83% 1% 39
5 VACCINE Address 34 12% 9% 265
6 BROADLY NEUTRALIZING ANTIBODIES Author keyword 33 75% 1% 24
7 HUMORAL PONSE PATHOGENS Address 27 92% 0% 11
8 CD4 BINDING SITE Author keyword 23 79% 0% 15
9 NEUTRALIZING ANTIBODIES Author keyword 22 17% 4% 115
10 IMMUNOL MICROBIAL SCI Address 21 15% 4% 129

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 BROADLY NEUTRALIZING ANTIBODIES 33 75% 1% 24 Search BROADLY+NEUTRALIZING+ANTIBODIES Search BROADLY+NEUTRALIZING+ANTIBODIES
2 CD4 BINDING SITE 23 79% 0% 15 Search CD4+BINDING+SITE Search CD4+BINDING+SITE
3 NEUTRALIZING ANTIBODIES 22 17% 4% 115 Search NEUTRALIZING+ANTIBODIES Search NEUTRALIZING+ANTIBODIES
4 GP120 19 16% 4% 111 Search GP120 Search GP120
5 4E10 18 83% 0% 10 Search 4E10 Search 4E10
6 2F5 15 71% 0% 12 Search 2F5 Search 2F5
7 2G12 15 73% 0% 11 Search 2G12 Search 2G12
8 MPER 14 59% 1% 16 Search MPER Search MPER
9 GP41 14 20% 2% 62 Search GP41 Search GP41
10 BROADLY NEUTRALIZING ANTIBODY 12 59% 0% 13 Search BROADLY+NEUTRALIZING+ANTIBODY Search BROADLY+NEUTRALIZING+ANTIBODY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CD4 BINDING SITE 397 86% 7% 204
2 PROXIMAL EXTERNAL REGION 277 76% 6% 194
3 HUMAN MONOCLONAL ANTIBODY 209 34% 17% 500
4 GP120 147 28% 15% 453
5 BROADLY NEUTRALIZING ANTIBODIES 136 62% 5% 139
6 HUMAN MONOCLONAL ANTIBODIES 135 29% 13% 395
7 ENV CLONES 130 80% 3% 82
8 CD4 BINDING 129 72% 3% 103
9 MUCOSAL SHIV CHALLENGE 118 95% 1% 39
10 2F5 114 86% 2% 59

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy 2014 49 149 82%
Antibodies in HIV-1 Vaccine Development and Therapy 2013 84 101 88%
Insights into the trimeric HIV-1 envelope glycoprotein structure 2015 4 58 93%
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies 2012 109 112 87%
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies 2004 502 145 74%
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies 2005 596 108 73%
GP120: Target for neutralizing HIV-1 antibodies 2006 272 172 78%
HIV-1 neutralizing antibodies: understanding nature's pathways 2013 60 179 78%
The role of HIV-specific antibody-dependent cellular cytotoxicity in HIV prevention and the influence of the HIV-1 Vpu protein 2015 4 59 59%
The Role of Antibodies in HIV Vaccines 2010 172 226 69%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 IAVI NEUTRALIZING ANTIBODY 154 87% 2.5% 75
2 DUKE HUMAN VACCINE 77 46% 4.2% 125
3 HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER 70 78% 1.5% 46
4 INT AIDS VACCINE INITIAT NEUTRALIZING ANTIBODY CT 69 83% 1.3% 39
5 VACCINE 34 12% 8.8% 265
6 HUMORAL PONSE PATHOGENS 27 92% 0.4% 11
7 IMMUNOL MICROBIAL SCI 21 15% 4.3% 129
8 NEUTRALIZING ANTIBODY 21 78% 0.5% 14
9 SCRIPPS HIV AIDS VACCINE IMMUNOL IMMUNOGEN 21 85% 0.4% 11
10 RETROVIRAL BIOL 15 77% 0.3% 10

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000197345 ENFUVIRTIDE//GP41//T 20
2 0.0000162400 HIV 1 GP41//GP120 CD4 INTERACTION//CD4 RECEPTOR
3 0.0000157950 UNITE RETROVIROL MOL//ENTROPY EVOLUTION RATE//HIV 1 MOTHER TO CHILD TRANSMISSION
4 0.0000119044 ANTI R7V ANTIBODIES//C ADE//T CELL INFECTION
5 0.0000114967 SIV//SHIV//SIMIAN IMMUNODEFICIENCY VIRUS
6 0.0000110223 PARTNERS AIDS//HIV PATHOGENESIS PROGRAMME//DORIS DUKE MED
7 0.0000108599 CCR5//MARAVIROC//CCR5 ANTAGONIST
8 0.0000104292 HGP 30//VACCINE DEV BRANCH//HIV 1 IMMUNOGEN
9 0.0000093871 CYANOVIRIN N//CV N//ACTINOHIVIN
10 0.0000080842 ELECTRON ION INTERACTION POTENTIAL//INFORMATIONAL SPECTRUM METHOD//DECEPTIVE IMPRINTING